These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24400729)

  • 1. Radionuclide imaging of drug delivery for patient selection in targeted therapy.
    Heskamp S; van Laarhoven HW; van der Graaf WT; Oyen WJ; Boerman OC
    Expert Opin Drug Deliv; 2014 Feb; 11(2):175-85. PubMed ID: 24400729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls.
    Tolmachev V; Stone-Elander S; Orlova A
    Lancet Oncol; 2010 Oct; 11(10):992-1000. PubMed ID: 20667780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating molecular nuclear imaging in clinical research to improve anticancer therapy.
    de Vries EGE; Kist de Ruijter L; Lub-de Hooge MN; Dierckx RA; Elias SG; Oosting SF
    Nat Rev Clin Oncol; 2019 Apr; 16(4):241-255. PubMed ID: 30479378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Molecular Image-Guided Cancer Radionuclide Therapy.
    Gao D; Sun X; Gao L; Liu Z
    Curr Drug Targets; 2015; 16(6):634-44. PubMed ID: 26028045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters Affecting the Enhanced Permeability and Retention Effect: The Need for Patient Selection.
    Natfji AA; Ravishankar D; Osborn HMI; Greco F
    J Pharm Sci; 2017 Nov; 106(11):3179-3187. PubMed ID: 28669714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs.
    Weber WA; Czernin J; Phelps ME; Herschman HR
    Nat Clin Pract Oncol; 2008 Jan; 5(1):44-54. PubMed ID: 18097456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology.
    Colombo I; Overchuk M; Chen J; Reilly RM; Zheng G; Lheureux S
    Methods; 2017 Nov; 130():23-35. PubMed ID: 28743635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls.
    Nakamura H; Fang J; Maeda H
    Expert Opin Drug Deliv; 2015 Jan; 12(1):53-64. PubMed ID: 25425260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular imaging in cancer therapy].
    Weber WA
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):810-7. PubMed ID: 20700780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
    Danhier F
    J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.
    Ryu JS; Raucher D
    Expert Opin Drug Deliv; 2015 Apr; 12(4):653-67. PubMed ID: 25350837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Imaging of IGF-1R in Cancer.
    Sun Y; Sun X; Shen B
    Mol Imaging; 2017; 16():1536012117736648. PubMed ID: 29169312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor Occupancy Imaging Studies in Oncology Drug Development.
    Burvenich IJG; Parakh S; Parslow AC; Lee ST; Gan HK; Scott AM
    AAPS J; 2018 Mar; 20(2):43. PubMed ID: 29520671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.
    Maeda H; Tsukigawa K; Fang J
    Microcirculation; 2016 Apr; 23(3):173-82. PubMed ID: 26237291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.
    Zarei O; Benvenuti S; Ustun-Alkan F; Hamzeh-Mivehroud M; Dastmalchi S
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2429-2446. PubMed ID: 27503093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody positron emission tomography imaging in anticancer drug development.
    Lamberts LE; Williams SP; Terwisscha van Scheltinga AG; Lub-de Hooge MN; Schröder CP; Gietema JA; Brouwers AH; de Vries EG
    J Clin Oncol; 2015 May; 33(13):1491-504. PubMed ID: 25779566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.